UK review pushes mental health, ADHD and autism care away from diagnosis as the sole gateway
England’s mental health and neurodevelopmental system is being asked to absorb a demand shift that is larger than its current design can handle. The executive summary of the independent review into mental health conditions, ADHD and autism argues that the country is no longer dealing only with rising referrals; it is dealing with a structure in which diagnosis has become the main route to support, even when people need help before an assessment is completed.
The review frames that as a dual failure. People wait too long for assessment and treatment, and support is too often withheld until a label is secured. For a system already under strain, the consequence is predictable: distress accumulates, impairment deepens, and families, schools and employers absorb the fallout while specialist services remain out of reach.
Rising distress is real, and it is concentrating in younger people
The clearest trend in the summary is the growth in common mental health problems, especially among children and young adults. The proportion of adults aged 16 to 64 years meeting criteria for a common mental disorder rose from 15.5% in 1993 to 22.6% in 2024. Among 16 to 24 year olds, the increase was from around 1 in 6 to 1 in 4, with young women now reporting the highest rates of any group.
Self-harm and eating disorders have also increased in young adults. The review is explicit that this is not simply a story of greater awareness or better recognition. The pattern is broad, sustained and tied to everyday functioning. In practical terms, more people are struggling to study, work, sustain relationships and manage the ordinary demands of daily life.
Severe mental illness has not followed the same upward trend. Population rates of schizophrenia and bipolar disorder have remained broadly stable. Even so, the burden on those living with these conditions remains profound, and too many still do not receive the level of treatment and continuity of care they need. The review keeps that group visible rather than folding all psychiatric need into the same policy frame.
ADHD and autism need better data, not looser definitions
The review draws a sharp distinction between population prevalence, administrative prevalence, demand for assessment and unmet need. In clinical terms, those are not interchangeable measures. Population prevalence estimates how many people meet criteria in the community. Administrative prevalence reflects who has entered the system and been recorded. Demand captures the pressure on services. Need can exist before any of those show up in an NHS dataset.
For ADHD, the review says the population prevalence appears broadly stable or only modestly increased over recent decades, but England lacks up-to-date population data. The most recent Mental Health of Children and Young People survey estimated ADHD prevalence at 3% among 5 to 15 year olds in 2017 using DSM-5 criteria. On the basis of those data points, the review projects a rough current prevalence of around 3.8% in that age group, while stressing the uncertainty around that estimate.
Administrative prevalence tells a very different story. Recorded ADHD prevalence more than six-fold in children aged 6 to 11 years, rising from 0.45% in 2000 to 2.70% in 2025. In those aged 12 to 17 years, it increased by more than 15-fold, from 0.26% to 3.88% over the same period. A separate line of evidence shows that socioeconomic disadvantage remains associated with higher ADHD incidence and prevalence, although the gap between the most and least deprived groups has narrowed.
Autism is treated in the same analytical frame. Both conditions are described as strongly genetically influenced and present from early life, shaping attention, communication, behaviour and learning. Some people live full lives with the right adjustments. Others face substantial difficulties and lifelong high support needs. The review resists collapsing those experiences into a single category of neurodivergence, because traits are not the same as a diagnosable condition.
Diagnosis matters, but it cannot remain the only access point
The central policy recommendation is a shift from a diagnosis-dependent system to a needs-led plus diagnosis model. Diagnosis can be clinically necessary, personally meaningful and essential to treatment. It can explain longstanding difficulties and open the door to specialist care, accommodations and practical support. For many families, a diagnosis reduces confusion and helps secure support in school, work and community settings.
Diagnosis can also mislead when it is inaccurate, delayed or used as the sole lens through which a person is seen. A label may obscure co-occurring conditions, environmental pressures or the social causes of distress. In neurodevelopmental care, waiting for the label before offering support can be especially damaging, because the period before assessment is often when problems are intensifying.
A one-sentence reality check sits at the heart of the review: support should not be withheld while someone is waiting for diagnosis.
Participation, not waiting lists, should be the outcome that counts
The review moves the metric of success away from assessments and queue length alone. It argues that increased participation in relationships, education, work, family and community life should be the primary outcome measure. Those domains are not peripheral to mental health; they are part of it. Secure, well-supported work offers structure, income, social connection and purpose, and can support recovery rather than merely follow it.
This is where the policy logic becomes more clinical than bureaucratic. If services only measure how many people have been assessed, they can miss whether anyone is actually functioning better. If schools, employers and local services are not part of the response, then healthcare ends up managing problems that are partly created or worsened outside healthcare.
The review calls for reform across mental health and neurodevelopmental care, increased capacity, digitally enabled care, clearer national standards and sustained investment. It also calls for action on the social and economic conditions that shape mental health and neurodevelopmental outcomes, alongside better measurement of whether public services are improving lives rather than simply moving people between waiting lists.
One blunt conclusion stands out: continuing as the system is now is not sustainable.
Data gaps, service pressure and the limits of current evidence
The review is careful about uncertainty. It acknowledges that evidence is incomplete, outdated or inconsistent in key areas, especially around ADHD and autism prevalence in England. Functional impairment is also not consistently defined or recorded, which makes trend analysis difficult and limits the precision of planning. Those gaps matter because they shape both policy and clinical triage.
The executive summary does not present a single treatment algorithm or a quick operational fix. Instead, it makes a public health argument: rising mental distress, long waits, and a system overly dependent on diagnosis are interacting problems. If service design does not shift, the people with the most severe and enduring needs will continue to be hardest to reach, while many others will keep waiting for support that could have started earlier.
The review closes the loop on a familiar but unresolved question in public mental health: how to build a system that recognises disorder without making diagnosis the price of entry. The answer offered here is structural, not cosmetic, and it depends on whether government and services can act on the evidence before more people are pushed further into need.